Related Articles
Platelet-activating factor promotes motility in breast cancer cells and disrupts non-transformed breast acinar structures
Diallyl trisulfide reverses drug resistance and lowers the ratio of CD133+ cells in conjunction with methotrexate in a human osteosarcoma drug-resistant cell subline
Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs
Diallyl trisulfide sensitizes human melanoma cells to TRAIL-induced cell death by promoting endoplasmic reticulum-mediated apoptosis
P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer